Showing results (161-170 of 287) with videos related to
Sort By:
Pageof 29
Lancet (London, England)|October 15, 1988
In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic fociI Savic, A Persson, P Roland, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Increased frequency of aberrant CSF circulation in schizophrenic patients compared to healthy volunteersG Oxenstierna, G Bergstrand, G Edman, et al.Psychopharmacology|October 20, 1999
A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brainY H Chou, P Karlsson, C Halldin, et al.Nuclear Medicine and Biology|June 26, 1999
Different brain radioactivity curves in a PET study with [11C]beta-CIT labelled in two different positionsC Lundkvist, C Halldin, C G Swahn, et al.Nuclear Medicine and Biology|November 14, 1997
[18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporterC Lundkvist, C Halldin, N Ginovart, et al.International Clinical Psychopharmacology|April 1, 1989
The new selective D2-dopamine receptor antagonist raclopride--pharmacokinetics, safety and tolerability in healthy malesL Farde, C von Bahr, A Wahlen, et al.The American Journal of Psychiatry|February 1, 1995
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoateS Nyberg, L Farde, C Halldin, et al.Nuclear Medicine and Biology|April 1, 1996
[11C]metaraminol, a false neurotransmitter: preparation, metabolite studies and positron emission tomography examination in monkeyK Någren, C Halldin, C G Swahn, et al.Nuclear Medicine and Biology|August 30, 2000
Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug developmentB Andrée, C Halldin, S O Thorberg, et al.Journal of Psychiatric Research|January 1, 1988
A twin study of amino acid concentrations in cerebrospinal fluidL Hagenfeldt, G Oxenstierna, G Alfredsson, et al.Pageof 29